Verrica shareholders re-elect three directors; ratify KPMG as auditor for FY2023

Verrica Pharmaceuticals Inc.

All three director nominees elected: Ballaron (16,697,734 for), Manning (16,965,570), Eichenfield (16,400,406); 17,862,320 broker non-votes.
Ratification of KPMG LLP as independent auditor for FY2023: 34,915,802 for, 1,088 against, 13,730 abstain.
83.46% of 41,852,053 outstanding shares were present or represented at the June 8, 2023 annual meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Verrica Pharmaceuticals Inc. shareholders approved Election of three nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. at the 2023-06-08 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-08

Exact text from the filing

Proposal No. 1 : Election of three nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Craig Ballaron 16,697,734 370,566 Paul B. Manning 16,965,570 102,730 Lawrence Eichenfield 16,400,406 667,894 Broker Non-Votes: 17,862,320. All nominees were elected.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Verrica Pharmaceuticals Inc. shareholders approved Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-06-08 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-08

Exact text from the filing

Proposal No. 2 : Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of KPMG LLP 34,915,802 1,088 13,730

View on SEC.gov

461 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Verrica Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-163516

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.